BIOGEN INC.·4

Feb 10, 5:05 PM ET

Singhal Priya 4

4 · BIOGEN INC. · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Biogen (BIIB) Head of Development Priya Singhal Sells Shares After RSU Conversion

What Happened
Priya Singhal, Head of Development at Biogen (BIIB), had restricted/derivative awards convert into common shares on Feb 6, 2026 (totaling 6,900 shares from two conversions: 2,217 and 4,683). Of those converted shares, 2,468 shares (1,056 + 1,412) were surrendered to cover tax liabilities (payment value reported at $201.18 per share, totaling $496,512). On Feb 9, 2026 she sold 2,660 shares in an open-market transaction at $199.83 per share for $531,548. After the conversions, withholding and the sale, roughly 1,772 shares from this conversion event remain (6,900 converted − 2,468 withheld − 2,660 sold = 1,772), though the filing does not state total company shares she owns post-transaction.

Key Details

  • Transaction dates and prices:
    • Feb 6, 2026: Conversion/exercise of derivatives/RSUs — 2,217 and 4,683 shares (acquired via conversion; $0 exercise price reported).
    • Feb 6, 2026: Tax withholding — 1,056 shares and 1,412 shares withheld at $201.18 (total ~$496,512).
    • Feb 9, 2026: Open-market sale — 2,660 shares at $199.83, proceeds $531,548.
  • Nature of transactions: M = exercise/conversion of derivative (RSU conversion), F = shares surrendered to pay tax liability, S = open-market sale.
  • Footnotes:
    • F1: One grant vests in three equal annual installments beginning 02/07/2024.
    • F2: Another grant vests in three equal annual installments beginning 02/06/2025.
  • Shares owned after transaction: The filing does not state total holdings; approximately 1,772 shares from this conversion event remain un-surrendered/un-sold.
  • Filing timeliness: Report filed 2026-02-10 covering transactions on 2026-02-06; the filing does not indicate a late report.

Context
These entries reflect RSU/derivative conversions and routine tax withholding rather than an out-of-pocket purchase. The sequence — conversion, withholding of shares for taxes, then an open-market sale — is common when equity awards vest (a form of cashless settlement). Such sales are often administrative (to cover taxes or diversify) and are not, by themselves, a clear signal of a change in insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-06
Singhal Priya
Head of Development
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-06+2,2178,488.143 total
  • Tax Payment

    Common Stock

    2026-02-06$201.18/sh1,056$212,4467,432.143 total
  • Exercise/Conversion

    Common Stock

    2026-02-06+4,68312,115.143 total
  • Tax Payment

    Common Stock

    2026-02-06$201.18/sh1,412$284,06610,703.143 total
  • Sale

    Common Stock

    2026-02-09$199.83/sh2,660$531,5488,043.143 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1]
    2026-02-062,2172,217 total
    Exercise: $0.00Exp: 2027-02-07Common Stock (2,217 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F2]
    2026-02-064,6839,367 total
    Exercise: $0.00Exp: 2028-02-06Common Stock (4,683 underlying)
Footnotes (2)
  • [F1]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.
  • [F2]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
Signature
/s/ Wendell Taylor, attorney-in-fact for Priya Singhal|2026-02-10

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT